Encompass Health adds new director committee roles

Encompass Health Corporation filed an amended report to update a recent Board change.

Rhea-AI Filing Summary

Encompass Health Corporation filed an amended report to update a recent Board change. The Board had unanimously approved the appointment of Cain A. Hayes as a director on January 30, 2026. The amendment notes that on February 19, 2026, the Board appointed Mr. Hayes to the Compensation and Human Capital Committee and the Compliance and Quality of Care Committee. This filing supplements an earlier report originally filed on February 2, 2026, by providing these committee assignments for the new director.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Encompass Health (EHC) disclose in this 8-K/A?

Encompass Health disclosed that its Board appointed Cain A. Hayes as a director. The amendment updates a prior filing to reflect his committee assignments, clarifying his governance role rather than signaling any financial or operational change at the company.

Who is the new director appointed to Encompass Health’s board?

The new director is Cain A. Hayes, whose appointment was unanimously approved by the Board on January 30, 2026. This amended filing primarily clarifies his subsequent committee assignments within the Board’s structure at Encompass Health Corporation.

Which board committees will Cain A. Hayes serve on at Encompass Health (EHC)?

Cain A. Hayes was appointed to the Compensation and Human Capital Committee and the Compliance and Quality of Care Committee. These committees oversee executive pay, workforce matters, and quality and compliance issues within Encompass Health’s governance framework.

Why did Encompass Health file an amended 8-K/A related to its new director?

The company filed the 8-K/A to amend and supplement an earlier report from February 2, 2026. The amendment adds the specific committee assignments for new director Cain A. Hayes, providing more complete disclosure of his responsibilities on the Board.

When did Encompass Health’s board approve the appointment of Cain A. Hayes?

The Board unanimously approved the appointment of Cain A. Hayes as a director on January 30, 2026. His committee assignments to key Board committees were later made effective on February 19, 2026, and are reflected in this amended filing.

Does this Encompass Health (EHC) 8-K/A include financial or earnings information?

No, this 8-K/A focuses on governance matters rather than financial results. It updates a prior disclosure by identifying the Board committees to which new director Cain A. Hayes has been appointed within Encompass Health’s board structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:20 PM EST Learn about SEC filing dates

false000078516100007851612026-02-192026-02-19

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): February 19, 2026

Encompass Health Corporation

(Exact name of Registrant as specified in its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-10315			63-0860407
(Commission File Number)			(IRS Employer Identification No.)

9001 Liberty Parkway, Birmingham, Alabama 35242

(Address of Principal Executive Offices, Including Zip Code)

(205) 967-7116

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.     Emerging growth company   ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			EHC			New York Stock Exchange

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Election of Director.

This Current Report on Form 8-K amends and supplements the Current Report on Form 8-K originally filed by Encompass Health Corporation (the “Corporation”) with the Securities and Exchange Commission on February 2, 2026 related to the appointment of a new member of the Board of Directors (the “Board”) of the Corporation. On January 30, 2026, the Board unanimously approved the appointment of Cain A. Hayes as director. On February 19, 2026, the Board appointed Mr. Hayes to its Compensation and Human Capital Committee and its Compliance and Quality of Care Committee.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

ENCOMPASS HEALTH CORPORATION
By:			/S/   Patrick Darby
			Name:			Patrick Darby
			Title:			Executive Vice President, General Counsel and Secretary

Dated: February 20, 2026

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.9 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.4 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.4 KB